ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Mundipharma clinical trials

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 120 studies whose lead sponsor is Mundipharma or one of 13 companies grouped under it. 2 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 13, 2026.

Our grouping of 18 registry names, not the registry’s. See them and correct one ↓

Pipeline: 1 program

Each counted once: 1 with a study Mundipharma leads registered in the last two years.

  • Phase 2

The 1 program — sign in to see the list, free: with every program, filter by condition or phase and sort by first study or primary completion.

“Registry” is the highest phase of Mundipharma’s own registered studies; Mundipharma’s own pipeline document is not read yet. “Primary completion” is the earliest date still ahead among its live studies when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced. Programs are read from ClinicalTrials.gov, joined across names by rules and decisions each recorded with its evidence.

What it is testing

The drugs Mundipharma’s studies test, most open studies first — 26 drugs with a page of their own. Each count opens the studies in search.

Open now Not open: under way, finished or stopped

Show 16 more

Coming up

2 of Mundipharma’s studies under way reach primary completion within a year. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. 1N’26
  2. D
  3. J’27
  4. F
  5. M
  6. 1A
  7. M
  8. J
  9. J
  10. A
  11. S
  12. O
  13. N

Add all 2 to your calendar (.ics) → With an account.

All 120 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now22%Not yet recruiting 1 · Recruiting 1
  • Under way, not recruiting11%
  • Completed9781%
  • Stopped early1513%Terminated 13 · Withdrawn 2
  • Status unknown or other54%

Phase

  • Phase 344
  • Phase 129
  • Phase 426
  • Phase 219
  • Early Phase 11

Where

  • United Kingdom25
  • Germany21
  • China18
  • Korea, Republic of18
  • Spain14
  • Hungary12

Over the years

  1. 07
  2. 08
  3. 09
  4. 10
  5. 11
  6. 12
  7. 13
  8. 14
  9. 15
  10. 1416
  11. 17
  12. 18
  13. 19
  14. 20
  15. 21
  16. 22
  17. 23
  18. 24
  19. 25
  20. 126

By the year each study started; 7 started before 2007. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to Mundipharma.

  • Mundipharma Research Limited
    Subsidiary
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    36 studies →
  • Mundipharma (China) Pharmaceutical Co. Ltd
    Regional office
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    19 studies →
  • Mundipharma Korea Ltd
    Regional office
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    16 studies →
  • Mundipharma Research GmbH & Co KG
    Subsidiary
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    16 studies →
  • Mundipharma K.K.
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    5 studies
  • Taiwan Mundipharma Pharmaceuticals Ltd.
    Regional office
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    5 studies →
  • Mundipharma AB
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    4 studies
  • Mundipharma Pharmaceuticals B.V.
    Regional office
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    3 studies →
  • Mundipharma Pte Ltd.
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    3 studies
  • Mundipharma Pharmaceuticals S.L.
    Regional office
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    2 studies →
  • Mundipharma SAS
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    2 studies
  • Mundipharma Manufacturing Pte Ltd.
    Subsidiary
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    2 studies →
  • Cinfa Biotech
    Acquired
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    2 studies →
  • Mundipharma Medical Company
    Subsidiary
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1 study →
  • Mundipharma-EDO GmbH
    Subsidiary
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1 study →
  • Mundipharma Pharmaceuticals Sdn. Bhd.
    Regional office
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1 study →
  • Mundipharma Oy
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1 study
  • Mundipharma Pharmaceuticals srl
    Regional office
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1 study →

Focus areas

Conditions Mundipharma leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.

Studies

Recruiting first, then most recently updated. Showing 50 of 120. Browse all 120 →